TITLE

PAEDIATRIC GASTROENTEROLOGY

PUB. DATE
February 2007
SOURCE
Gut;Feb2007 Supplement 1, Vol. 56, p47
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on paediatric gastroenterology in Great Britain and offers recommendations related to the diagnosis, treatment, and effective management of children with gastrointestinal (GI) diseases. Information on several hospitals providing liver disease management and transplantation services in the country are mentioned. As stated, children with inflammatory bowel disease should be looked after in a child friendly setting and by paediatric gastroenterologists.
ACCESSION #
67205572

 

Related Articles

  • De novo Crohn's post Liver Transplantation: A rare case. Srinivasan, Sridhar // Internet Journal of Gastroenterology;2008, Vol. 6 Issue 2, p1 

    Immunosuppressive therapy is well established for treating inflammatory bowel disease (IBD). However we present a patient who developed IBD while on sufficient immunosupression.

  • THE CLINICAL COURSE OF ULCERATIVE COLITIS AFTER ORTHOTOPIC LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS. Seddon, A. J.; Ho, G. T.; Therapondos, G.; Hayes, P. C.; Satsang, J. // Gut;Apr2004 Supplement 3, Vol. 53, pA2 

    Primary sclerosing cholangitis (PSC) is strongly associated with ulcerative colitis (UC). In patients with advanced liver disease secondary to PSC, orthotopic liver transplantation (OLT) remains the only therapeutic option. Previous reports on the course of UC are conflicting. Researchers...

  • HIRSCHSPRUNG'S DISEASE; DIAGNOSIS AND MANAGEMENT: EXPERIENCE AT IBN-E-SIENA AND NISHTAR HOSPITAL, MULTAN. Ishfaq, Muhammad; Ahmad, Umar Farooq; Manzoor, Saima // Professional Medical Journal;2014, Vol. 21 Issue 1, p020 

    Objective: To determine the frequency of Hirschsprung's Disease as a cause of neonatal intestinal obstruction, to compare the results of treatment with others and to suggest means and ways to improve the deficiencies in our circumstances. Place and duration of study: Nishtar hospital and...

  • Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. Ananthakrishnan, Ashwin N.; McGinley, Emily L. // Journal of Crohn's & Colitis;Mar2013, Vol. 7 Issue 2, p107 

    Abstract: Introduction: Serious infections are an important side effect of immunosuppressive therapy used to treat Crohn''s disease (CD) and ulcerative colitis (UC). There have been no nationally representative studies examining the spectrum of infection related hospitalizations in patients with...

  • TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease. Altwegg, Romain; Vincent, Thierry // Mediators of Inflammation;2014, Vol. 2014, p1 

    Since their appearance in the armamentarium for inflammatory bowel disease (IBD) more than a decade ago, antitumor necrosis factor (TNF) inhibitors have demonstrated beneficial activity in induction andmaintenance of clinical remission,mucosal healing, improvement in quality of life, and...

  • Single Surgeon Experience with Laparoscopic Surgery in Pediatric Patients with Inflammatory Bowel Disease. Huang, Renee; Koleilat, Issam; Lee, Edward C. // Journal of Laparoendoscopic & Advanced Surgical Techniques;Jan2013, Vol. 23 Issue 1, p61 

    Purpose: Laparoscopic management of inflammatory bowel disease (IBD) has been well established in adults. Its efficacy and safety are less defined in pediatrics. We reviewed our single surgeon laparoscopic experience with pediatric IBD patients. Patients and Methods: All consecutive patients 17...

  • Topiramate Use Does Not Reduce Flares of Inflammatory Bowel Disease. Crockett, Seth; Schectman, Robin; Stürmer, Til; Kappelman, Michael // Digestive Diseases & Sciences;Jul2014, Vol. 59 Issue 7, p1535 

    Background: Additional medications are needed for inflammatory bowel disease (IBD) as existing therapies are incompletely effective and can be costly and toxic. Preclinical studies suggest that topiramate (an anticonvulsant) may have disease-modifying properties in IBD, but its efficacy in...

  • Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFa therapy: results from the COIN study. van der Valk, Mirthe Emilie; Mangen, Marie-Josée J.; Leenders, Max; Dijkstra, Gerard; van Bodegraven, Ad A.; Fidder, Herma H.; de Jong, Dirk J.; Pierik, Marieke; van der Woude, C. Janneke; Romberg-Camps, Mariëlle J. L.; Clemens, Cees H. M.; Jansen, Jeroen M.; Nofel, Mahmmod; van de Meeberg, Paul C.; van der Meulen-de Jong, Andrea E.; Ponsioen, Cyriel Y.; Bolwerk, Clemens J. M.; Vermeijden, J. Reinoud; Siersema, Peter D.; van Oijen, Martijn G. H. // Gut;Jan2014, Vol. 63 Issue 1, p72 

    Objective The introduction of anti tumour necrosis factor-a (anti-TNFa) therapy might impact healthcare expenditures, but there are limited data regarding the costs of inflammatory bowel diseases (IBD) following the introduction of these drugs. We aimed to assess the healthcare costs and...

  • Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA. Gajendran, Mahesh; Umapathy, Chandraprakash; Loganathan, Priyadarshini; Hashash, Jana; Koutroubakis, Ioannis; Binion, David; Hashash, Jana G; Koutroubakis, Ioannis E; Binion, David G // Digestive Diseases & Sciences;Feb2016, Vol. 61 Issue 2, p389 

    Background: Inflammatory bowel disease (IBD) is a chronic, debilitating condition with high emergency department (ED) utilization. We aimed to investigate the utilization patterns of ED by IBD patients and measure hospitalization and surgical rates following ED visits.Methods:...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics